Jefferies Financial Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Buy |
10,313,733
+10,068,479
| +4,105% | +$23.3M | 0.2% | 58 |
|
|
2025
Q1 | $341K | Buy |
+245,254
| New | +$341K | ﹤0.01% | 966 |
|
|
2024
Q4 | – | Sell |
-73,857
| Closed | -$148K | – | 1467 |
|
|
2024
Q3 | $148K | Sell |
73,857
-183,837
| -71% | -$370K | ﹤0.01% | 974 |
|
|
2024
Q2 | $577K | Buy |
257,694
+209,594
| +436% | +$469K | 0.01% | 702 |
|
|
2024
Q1 | $138K | Buy |
+48,100
| New | +$138K | ﹤0.01% | 1078 |
|